A phase II study of PF-06842433 for Pneumococcal infections
Latest Information Update: 08 May 2019
Price :
$35 *
At a glance
- Drugs PF-06842433 (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 08 May 2019 New trial record
Latest Information Update: 08 May 2019